C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

C3.ai has the ingredients to build a sustainable enterprise AI business. There are risks that could derail C3.ai's expansion.

July 28, 2025 This list ranks the top AI entrepreneurs based on verified performance and measurable impact. Each leader has ...

A number of planning applications have been submitted to Southend Council over the last week. Below is a listed overview of all the applications submitted to Southend Council for the week ending July ...

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of C3.ai's market ...

C3.ai announced today that CEO Tom Siebel would be stepping down and that the company was in the process of looking for its ...

The stocks bucked a mostly optimistic broader market, with the tech-heavy Nasdaq and the S&P 500 both up by 0.18 percent and ...

C3 AI founder and Chief Executive Officer Tom Siebel today announced that he will step down because of health issues.

Televisions LG's C3 OLED TV is the best cheap OLED TV you can buy - get it before it's gone Seasonal Sales How low can it go?

Shares of artificial intelligence (AI) software company C3.ai (NYSE:AI) fell 10% in the afternoon session after the company ...